A clinical-stage biotechnology company focused on developing RNA-based medicines designed to upregulate protein expression to treat diseases caused by haploinsufficiency. Its pipeline is built on the proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) platform, with lead programs target...
2 members of Congress have disclosed 2 trades in Stoke Therapeutics Inc. (STOK), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-11-06 | Rohit Khanna | buy | $1K – $15K |
| 2018-08-14 | JAMES B. RENACCI | sell | $15K – $50K |